IPP Bureau
Artificial intelligence facilitates low-cost drug repurposing, says GlobalData
By IPP Bureau - February 11, 2023
The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights the key company collaborations in pharma to advance AI-powered drug repurposing techniques.
Pfizer appoints Meenakshi Nevatia as MD and Additional Director
By IPP Bureau - February 10, 2023
She is a seasoned leader with nearly 30 years of business leadership and consulting experience with top companies such as Mckinsey and Co, Novartis Pharmaceuticals and Stryker India Pvt. Ltd.
Lupin receives approval from USFDA for Glycopyrrolate Injection USP
By IPP Bureau - February 10, 2023
The approval for Glycopyrrolate clears the path for more internally manufactured injectable products
Healthcare Global Enterprises revenue up 19%
By IPP Bureau - February 10, 2023
Technology and innovation play a pivotal role towards enhancing healthcare systems, increasing access to healthcare services, and reducing costs of therapies and consultations
Aurobindo Pharma Q3 FY23 net profit down 18.7% at Rs 491 Crores
By IPP Bureau - February 10, 2023
Revenue from operations during the quarter was up by 6.7 per cent to Rs 6,407.10 crore against Rs 6,002.2 in the same period last fiscal.
Dr. Reddy’s included in Bloomberg Gender-Equality Index for 6th year in a row
By IPP Bureau - February 09, 2023
The company has also been named among global sustainability leaders for the 7th year in a row in the Dow Jones Sustainability Index in the Emerging Markets category
Windlas Biotech appoints Komal Gupta as CEO
By IPP Bureau - February 09, 2023
The company is in the process of appointing the new Chief Financial Officer shortly and in the interim, Komal Gupta will continue as CFO
Jagsonpal Q3 FY23 revenues grew by 11.6% to Rs. 60.1 Cr; PAT up by 47.1%
By IPP Bureau - February 09, 2023
Operating EBITDA grew by 82.7 % to Rs. 14.4 crore, EBITDA margin at 23.9%, and Profit After Tax (PAT) grew by 47.1% to Rs. 7.8 crore
JB Pharma records revenue growth of 32% to Rs. 793 Cr in Q3 FY23
By IPP Bureau - February 09, 2023
Profit after Tax stood at Rs. 106 crore as compared to Rs. 84 crore registering growth of 26%
IOL Chemicals and Pharmaceuticals Q3 FY23 income down 6%
By IPP Bureau - February 09, 2023
The company completed paracetamol capacity expansion by 1,800 MTPA and the company is now focusing on frugal manufacturing practices to reduce raw material cost and expand margins
H2 2022 sees 10 billion drop in total forecast sales of COVID-19 vaccines between 2021 and 2028, says GlobalData
By IPP Bureau - February 09, 2023
The forecast across the seven years between 2022 and 2028 saw an average decline of 7%, resulting in a $10 billion drop in the total forecast sales between 2021 and 2028
Alembic Pharmaceuticals Q3 FY23 revenue up 19% to Rs. 1,509 Cr
By IPP Bureau - February 07, 2023
Net sales for 9M FY23 up 9% to Rs. 4,246 crore and net profit for 9M FY23 at Rs. 189 crore
Vidya Balan launches cancer prevention initiative SEEDS
By IPP Bureau - February 07, 2023
SEEDS is a mnemonic for Shun Tobacco, Eat Correctly, Exercise Regularly, Dump obesity and excess alcohol, and Stay vigilant about your family history aims at making more and more people aware about the tenets of cancer prevention
Need a paradigm shift for popularising ayurveda in India
By IPP Bureau - February 07, 2023
For discovery or for standardization, Ayurveda colleges/institutes need to collaborate closely with Phytochemists, Pharmacologists, and Toxicologists from premier institutions
Bal Pharma posts Q3 FY2023 profit at Rs. 59.16 lakhs
By IPP Bureau - February 07, 2023
The company has reported total income of Rs.77.0791 crores during the period ended December 31, 2022 as compared to Rs.69.9191 crores during the period ended December 31, 2021.
